ArticleRheumatology advances in practice2025

Impact of disease manifestations on first biologic drug survival in axial spondyloarthritis: a real-life Canadian study.

Raphaël Hurtubise et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.